George H. Lowell - Concepedia

Concepedia

Author

George H. Lowell

Walter Reed Army Institute of Research

Also Known As

G H Lowell, G LOWELL, G Lowell, G. H. Lowell, G.H. Lowell, George H Lowell, George H. Lowell, George Lowell, George H. Lowell

56

Publications

2.5K

Citations

31

H-Index

63

Concepts

All Affiliations

Walter Reed Army Institute of Research Israel Defense Forces Medical Corps University of Michigan SNC-Lavalin (Canada)

GH

About

George H. Lowell is an author at Walter Reed Army Institute of Research specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	33	2.2K
2	Allergy	6	6	394
3	Cell Biology	4	4	179
4	Natural Sciences	2	2	139
5	Cellular Physiology	1	1	27

George H. Lowell

×

37

Publications

2.5K

Citations

31

H-Index

	Year	Citations
Oral <i>Salmonella typhimurium</i> Vaccine Expressing Circumsporozoite Protein Protects Against Malaria Jerald Sadoff, W. Ripley Ballou, Louis S. Baron, Science MalariaImmunologyImmunodominanceVaccine TargetSporozoite Challenge	1988	246
Proteosome-Lipopeptide Vaccines: Enhancement of Immunogenicity for Malaria CS Peptides George H. Lowell, W. Ripley Ballou, L F Smith, Science VaccinationMucosal VaccinationMedicineMalaria Cs PeptidesImmunology	1988	114
Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory IgA Aldo Tagliabue, L Nencioni, L Villa, Nature Autoimmune DiseaseAllergyMucosal ImmunologyHumoral ResponseImmunology	1983	114
HIV-1 Neutralizing Antibodies in the Genital and Respiratory Tracts of Mice Intranasally Immunized with Oligomeric gp160 Thomas C. VanCott, Robert W. Kaminski, John R. Mascola, The Journal of Immunology Candidate Hiv-1 VaccineImmunologyImmunodominanceImmunotherapyHuman Retrovirus	1998	111
Safety and Immunogenicity of a Proteosome- <i>Shigella flexneri</i> 2a Lipopolysaccharide Vaccine Administered Intranasally to Healthy Adults Louis Fries, Andrew Montemarano, Corey P. Mallett, Infection and Immunity	2001	107
Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models Nadav Orr, Guy Robin, Dani Cohen, Infection and Immunity Shigella LipopolysaccharideImmunologyImmunodominanceImmunotherapyCross-protection	1993	100
Immunoglobulin M, A, and G antibody response to lipopolysaccharide O antigen in symptomatic and asymptomatic Shigella infections Dani Cohen, Colin Block, Manfred S. Green, Journal of Clinical Microbiology VaccinationVeterinary VaccineO AntigenPathogenesisImmunology	1989	99
Peptides bound to proteosomes via hydrophobic feet become highly immunogenic without adjuvants. George H. Lowell, L F Smith, Robert C. Seid, The Journal of Experimental Medicine MedicineNatural SciencesSynthetic PeptideImmunologyPeptide Engineering	1988	83
Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection Corey P. Mallett, Thomas L. Hale, Robert W. Kaminski, Infection and Immunity VaccinationShigella InfectionPulmonary MucosaMucosal VaccinationLethal Pneumonia	1995	80
Intranasal Immunization with Multivalent Group A Streptococcal Vaccines Protects Mice against Intranasal Challenge Infections Mary A. Hall, Steven D. Stroop, Mary C. Hu, Infection and Immunity VaccinationHexavalent ProteinMucosal VaccinationVaccine DevelopmentSalivary Antibodies	2004	77

Page 1